Abstract
Two patients were treated with treatment-resistant polymyositis with intravenous immunoglobulin over four days at a dose of 0.4 g/kg/day. Clinical recovery followed within two months. Serum creatine kinase (CK) activity decreased to normal, and a clear improvement in muscle strength was observed. One patient showed neither clinical relapses nor increase in serum CK activity after 20 months. The other showed a mild increase in serum CK activity after 24 months and was successfully retreated with intravenous immunoglobulin. There were no significant adverse side effects.
| Original language | English |
|---|---|
| Pages (from-to) | 60-62 |
| Number of pages | 3 |
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 55 |
| Issue number | 1 |
| Publication status | Published - 1992 |
ASJC Scopus subject areas
- Psychiatry and Mental health
- Neuroscience(all)
- Neuropsychology and Physiological Psychology